How Human Challenge Trials Can Accelerate Vaccine Development

Other recent posts

Blog

Tripledemic Takedown: How Human Challenge Trials are Ideal to Expedite Multivalent Vaccine Development

Introduction The recent rise of the "tripledemic" – the concurrent spread of the influenza virus, SARS-CoV-2 virus, and respiratory syncytial virus (RSV) – is posing significant risks, especially to older...

Read more

Article

Human SARS-CoV-2 challenge uncovers local and systemic response dynamics | Nature

View Link

If you’re a potential customer, job seeker, health professional or an investor, find out how hVIVO can help you.